The use of intravascular ultrasound catheters to produce images of lumen and plaque cross-sectional areas has had a profound effect on the practice of interventional cardiology. This imaging modality provides, for the first time, a low-power microscopic view of vascular anatomy within a living patient. This article will review some of the advantages of intravascular ultrasound imaging compared with angiography when used for diagnostic or interventional therapeutic procedures.
C oronary angiography is the primary mode of imaging coronary artery disease and guiding interventional procedures. Although coronary angiography was essential for the development of catheter-based coronary interventions, as the complexity of interventional cases increased, several limitations of angiography surfaced. Problems associated with coronary intervention, such as acute closure and restenosis, are related in part to properties of the lesion. Angiographic studies have reported inconsistent predictors of such adverse events. 1,2 One of the main reasons for this inconsistency is the limited power of angiography to delineate the complex anatomy of coronary atherosclerotic lesions. Intravascular ultrasound (IVUS) is a technique that provides two-dimensional, tomographic views of the coronary lumen and wall morphology in vivo, which has several advantages compared with angiography. 3 This article reviews the limitations of angiography and describes the information that IVUS imaging provides to complement angiography during diagnostic and interventional procedures. The ability of IVUS to evaluate lesion characteristics and dimensions alters therapeutic decisions and permits the operator to optimize each intervention.
Lesion Evaluation
Evaluation of coronary atherosclerotic lesions by angiography has been described by the joint American College of Cardiology/American Heart Association (ACC/AHA) committee. 4 This system delineates lesions by the degree of eccentricity and complexity. However, this analysis is limited by the ability of angiography to visualize only the lumen and not the atherosclerotic plaque itself.
IVUS provides new insights for lesion evaluation because it produces a tomographic view of the artery and it is the only technique that permits visualization of the diseased artery wall in vivo. This capability is especially useful for diagnosing disease when vessels overlap or if there is a short stenosis. In addition, IVUS images are at a higher magnification than angiography, and its internal scale has been shown to be more accurate than angiographic assessment of plaque dimensions. Moreover, the ability of angiography to provide information on tissue characterization is limited. The following discussion will attempt to describe these differences between angiography and IVUS.
Tomographic Imaging
An angiogram shows a longitudinal, two-dimensional view of the lumen of the vessel and does not directly show us the pathology, that is, the atherosclerotic plaque. If the plaque impinges on the lumen, then the indentation is used as a measure of the severity of the atherosclerosis. This method may lead to a false sense of security for several reasons. Because the lumen edges of an angiogram may have a smooth border, we assume that there is not a lot of disease in the vessel. 5 Pathologic studies show that the amount of atherosclerosis is underrepresented by angiography. [6] [7] [8] [9] [10] [11] [12] In Fig 1A, the angiogram of a right coronary artery (RCA) shows severe stenosis in the mid portion, but it was felt that the rest of the artery did not have significant disease. Unfortunately, this patient did not survive an intervention of balloon angioplasty for the mid RCA stenosis (this study was performed before stents became available). The corresponding pathologic cross sections ( Fig 1B) were taken every 5 mm along the length of the RCA, posterior descending, and posterior lateral branches. The diffuse nature of atherosclerosis is shown in every cross section. Although this phenomenon was counterintuitive to most angiographers, it became more readily accepted throughout the 1980s with the concept of vascular remodeling and compensatory dilatation proposed by Glagov et al. 13 In their pathologic study of 125 left main coronary arteries, it was shown that as the amount of atherosclerosis increased, the outer diameter of the vessel increased but the lumen remained constant until approximately 40% of the cross-sectional area was filled with plaque. At that point, the outer dimension could not enlarge adequately to compensate for the increase in plaque area; the lumen became narrow and only then would it be recognized as diseased on angiography. As shown in Fig 2, the lumens from artery sections 1 through 4 would all appear to be the same on angiography, and all four would be erroneously considered normal. In distinction to angiography, IVUS looks beyond the lumen and reflects information directly about the pathology within the arterial wall. Thus, IVUS can distinguish normal from progressive stages of atherosclerosis in vivo. 14 IVUS studies confirm that arteries frequently expand radially as the 
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plaque enlarges while maintaining the lumen cross-sectional area so that adequate blood flow is provided (Fig 3) .
Vessel Overlap or Short Stenoses
Several in vitro and clinical studies have shown that IVUS and angiographic measurements of lumen diameter correlate well when there is minimal disease or if the lumen is circular. 15 However, angiography can be misleading, especially when there is an overlap of vessels or if a short stenosis is present. Figure 4 provides evidence for what has been called a ''napkin ring '' stenosis. 16 This is a very short stenosis, only 1 to 2 mm in length, such that even in multiple angiographic projections, contrast is in front of or behind the stenosis, which makes the stenosis appear less significant than it is. The angiogram of this symptomatic patient suggests that a mild stenosis is present in the proximal left anterior descending coronary artery (LAD), but on IVUS imaging, the real stenosis is in the mid LAD, where the ultrasound catheter is wedged into the speckled reverberations of plaque. The mid LAD was treated with balloon angioplasty with relief of the patient' s symptoms. 
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Accurate Measurements-Magnification and Scale
Magnification and scaling errors reveal another major difference between angiography and IVUS for quantitative analysis. 17, 18 With angiography, there are significant magnification assumptions when using the guiding catheter as the ruler. A 2.7-mm guide catheter represents only 11 pixels in a 640 ϫ 480 pixel matrix. When measuring an artery edge, one could easily be off by 1 or 2 pixels, which for an artery between 1 and 4 mm is nearly 10% of the ruler. With IVUS imaging, the ''ruler'' is inherent in the image and is based on the speed of sound in tissue at 37°C. These observations suggest that quantitative coronary angiography has been given too much credence in our literature and design of studies. We should not confuse the reproducibility that computerized measurements provide with accuracy in representing complex luminal topography. It is similar to squeezing a 3-decimal place accuracy from a technique whose scale may be incorrect by several tenths of a millimeter.
Misdiagnosis of Eccentric Lesions
Another area where there is disagreement between ultrasound and angiography is in the description of plaque eccentricity. 14,19-21 As schematically shown in Fig 5 , an angiogram that is described as showing a concentric lesion may, in fact, appear to be eccentric on cross-sectional imaging with ultrasound because the plaque itself is not visualized on the angiogram. Conversely, an eccentric plaque by angiography may appear to be concentric on cross-sectional imaging with ultrasound, as shown in the right-hand panel. This discordance between angiography and ultrasound for the description of plaque eccentricity occurs in approximately 20% of lesions. This observation undermines the validity of this angiographic descriptor as a predictor of responses to coronary interventions.
Tissue Characterization
Because angiography describes only the lumen of the vessel, this method cannot identify characteristics of the plaque beyond gross thrombus or calcification. Ultrasound patterns of tissue reflection can be used to characterize more subtle plaque composition. [22] [23] [24] [25] Although calcification can be visualized with fluoroscopy, IVUS provides information about plaque morphology and composition such as fibrous tissue and lipid components or intralumi- (1) calcium has the unique characteristic of being intensely echo reflective at the initial interface with dropout of echoes peripherally, which is termed shadowing ( Fig 7A) ; (2) using the same description, microcalcification can be identified as a very small area, 0.1 to 0.2 mm in diameter with intense echo reflections and a small radiating arc of shadowing behind it ( Fig 7B) ; (3) a fibrous acellular capsule (Fig 7C) appears on ultrasound as an intense echo reflection that may be equal or greater than the adventitia echogenicity, but it is distinguished from calcification because there is no shadowing behind it; (the next three categories show a more mixed pattern) (4) mixed cellularity interspersed within fibrous tissue is depicted on ultrasound images as a homogenous black and white speckled pattern with moderate echogenicity ( Fig 7D) ; (5) as fatty elements increase within the plaque, the echogenicity decreases as reflected in the fibrofatty plaque of Fig  7E , which has more black or echolucent areas within the echogenic fibrous tissue; and (6) a large deposition of lipid or necrotic tissue within the body of the plaque is more likely to be represented by a homogenous echolucent zone as shown in Fig 7F. Angiography may also be misleading in the diagnosis of thrombus formation. This can have significant implications in terms of the type of treatment that is attempted. An example of an apparent thrombus diagnosed by angiography is depicted in Fig 8. Most investigators report a high sensitivity of identifying calcium as a hyperechogenic area with shadowing. [26] [27] [28] Unfortunately, the ability of IVUS to distinguish fibrous from fatty tissue becomes less exact with sensitivity on the order of 50%. 29 It would be beneficial if IVUS images could consistently and accurately identify those plaques with a thin fibrous capsule and a lipid-rich core that are ripe for rupture (Fig 9) . 30, 31 This type of histologic pattern has been described as a likely precursor to acute plaque rupture and thrombus formation that may precipitate unstable syndromes or acute myocardial infarction. 32, 33 Unfortunately at the present time, the sensitivity for identifying these plaques is limited, and we have not used this information to preemptively treat a plaque based solely on its tissue components of a lipid core. It has been reported that analysis of unprocessed radiofrequency (RF) signals may work better for tissue characterization than conventional video IVUS images. 34 Moore et al performed RF analysis in an in vitro setting and showed that parameters of power and spectral slope could discriminate between various tissue types. Clinical studies are needed to test if the RF analysis is more reliable than the image interpretation computer in our brain.
Representation of Calcium Amount and Position
One of the important observations of IVUS is the recognition of a higher incidence of plaque calcifi- 
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cation than is appreciated by angiography. [35] [36] [37] Angiography identifies calcium at the site of a stenosis in only 15% of cases, whereas some degree of calcium is seen by ultrasound in up to 85% of these stenoses. The high sensitivity for depicting calcified areas of plaque has been useful in showing the distribution of calcium throughout the length and circumference of an artery on a micro-anatomic scale. 38, 39 As shown in Fig 10, calcified areas frequently occur at the base of the plaque but may subtend a variable circumference. Figure 10 shows calcified plaque at the lumen-plaque interface. These types of plaque are very resistant to balloon dilatation alone and impede stent expansion. When calcification is seen at the lumen-plaque interface, rotational atherectomy is usually necessary. Understanding the composition and biomechanical hardness of the plaque may be very useful when deciding what type of interventional device should be used.
Balloon Angioplasty
Overestimation of Percutaneous Transluminal Coronary Angioplasty (PTCA) Effect
In vitro studies using IVUS before and after balloon dilatation of atherosclerotic segments help to explain the mechanism of action of balloon angioplasty. Histologic studies show that the plaque is frequently torn at its thinnest segment or, if the plaque is calcified, the tear usually occurs at the junction of fibrous tissue and the calcified portion. [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] Compared with histologic assessment, IVUS has the benefit of 
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being able to image the artery before, as well as after, balloon dilatation. 50 As shown in Fig 11, IVUS images before and after balloon dilatation show that the lumen enlarges because of plaque fracture and separation of the torn ends. In addition, a new echolucent zone behind the plaque corresponds to dissection of the artery where the plaque is separated from the media. Occasionally, when larger balloons are used, the entire plaque may be rotated free from the media due to torsional forces that leave an entire ring of dissection around the circumference of the plaque. These dissections do not necessarily result in collapse of the plaque into the artery because it may be supported at its proximal and distal ends to the vessel wall.
When IVUS imaging was initially applied to patients who had balloon angioplasty, some of the observations were quite unexpected. 51, 52 As opposed to the angiographic results that suggested that a large lumen had been obtained, the usual finding with IVUS was that only a relatively small tear had occurred in the plaque with separation of the torn ends (Fig 12) . One was immediately impressed with the large amount of residual plaque that remained after balloon dilatation. 53 After seeing IVUS images, one could understand how easily restenosis occurs by elastic recoil and mild intimal proliferation; the wonder was how balloon dilatation yielded as high a degree of long-term success as it did.
The second major observation on the mechanism of balloon dilatation was the change in the lumen area from systole to diastole once the plaque had been fractured by the balloon. Although the volume of plaque had not been altered by balloon dilatation, the lumen cross-sectional area was dramatically increased by pulsatile blood flow in diastole. Conceptually, the plaque acts as a scar that immobilizes the wall of the artery. By cutting the plaque, balloon dilatation permits freer mobility of the arterial wall in response to the change in lumen pressure, thus increasing blood flow. 54
Assessment of Dissections
A dissection after balloon angioplasty was originally thought to be a predictive marker of acute closure; however, abrupt closure occurs in only 5% of PTCAs with angiographic signs of dissection. 55 Inducing dissections has been considered an integral part of lumen enlargement with balloon angioplasty, but not all dissections are equivalent. A dissection represents an adverse event when it compromises the lumen. If a dissection is associated with less than Thrombolysis in Myocardial Infarction (TIMI) 3 flow, it should be treated. However, when dissections are associated with TIMI 3 flow, further evaluation beyond angiographic assessment should be considered, such as IVUS interrogation 56 or coronary flow measurements. IVUS can detect circumferential and longitudinal extension of plaque fracture or dissection after balloon angioplasty. 51, 57 In a study comparing quantitative coronary angiography and IVUS, 58 a large discrepancy between these two modalities was reported, particularly when dissections were present after balloon angioplasty. These results indicate that angiography is not an optimal means to evaluate the vessel lumen after trauma from balloon dilatation. A case example of how IVUS helps in the decision to place a stent for the treatment of a coronary dissection is shown in Fig 13. 
Other Stenoses Within the Target Vessel
IVUS may be helpful during percutaneous coronary interventions to discover other lesions in the vessel that require treatment to obtain an optimal result. An example of this is shown in Fig 14. 
Underestimation of Vessel Size
Many studies have shown that a major determinant of restenosis is the percent diameter stenosis or minimal luminal diameter achieved after intervention. 59-65 Based on these findings, Don Baim introduced the so-called ''the bigger, the better'' doctrine. Although this rule of thumb may be appropriate for stents and directional atherectomy, indiscriminate use of balloons larger than the angiographic reference segment lumen may result in unacceptably high rates of ischemic complications after PTCA. 66, 67 Since its initial description by Andreas Gruntzig in 1978, 68, 69 PTCA has been performed by selection of a balloon with a nominal diameter approximating that of the normal-appearing reference segment adjacent to the lesion. A distinction needs to be made between the angiographic definition of artery size and the vessel size observed on IVUS. Whereas angiography uses the proximal reference lumen diameter to denote the artery size, IVUS defines the vessel size as the media-to-media diameter. Because arterial remodeling with compensatory vessel enlargement develops to preserve the lumen, 7,13,70 the vessel size by IVUS may be significantly greater than the lumen size by angiography. The extent of atherosclerosis in both the lesion and reference segments can be accurately measured on-line with IVUS imaging. [71] [72] [73] It was hypothesized that IVUS guidance could be used safely to accommodate oversized balloons in selected patients undergoing PTCA. Stone et al 74 showed that despite the presence of atheromatous remodeling, IVUS permits the safe use of balloons traditionally considered oversized, resulting in significantly improved luminal dimensions without increased rates of dissection or ischemic complications (Clinical Outcomes With Ultrasound Trial [CLOUT] Pilot Trial). Because the degree of plaque burden and the true vessel size can be determined only with IVUS, the use of ultrasound is thought to be essential for the accurate selection of properly sized balloons if an aggressive balloon strategy is to be safely performed. 74 Figure 15 shows an example how quantitative coronary angiography (QCA) may be misleading compared with IVUS imaging for assessing the artery size.
Understanding the Mechanisms of Restenosis
Restenosis remains a major limitation to percutaneous coronary revascularization. It occurs in 30% to 50% of transcatheter procedures within the first 6 months. [75] [76] [77] [78] Animal models, 79-82 human necropsy studies, 43,83-92 and analyses of retrieved atherectomy specimens [93] [94] [95] [96] [97] [98] [99] originally suggested that an exaggeration of the normal reparative processes after angioplasty-induced local vessel trauma leads to uncontrolled smooth muscle cell proliferation and restenosis. [100] [101] [102] However, these early studies that showed restenosis was due primarily to intimal hyperplasia may have been misleading. Animal and clinical studies suggest that arterial remodeling with constriction of the adventitia might be a major contributing factor to the development of restenosis. [103] [104] [105] [106] [107] [108] [109] [110] [111] Using serial IVUS, Mintz et al observed that two thirds of restenosis was due to adventitial contraction, or ''negative remodeling,'' and only one third of restenosis was explained by intimal proliferation. 112 Kimura et al reported that the time course of arterial remodeling after coronary angioplasty or atherectomy was characterized by early enlargement of the vessel (1 day to 1 month) and late constriction of the vessel (1 to 6 months). 113 They called the early and late vessel changes adaptive and constrictive remodeling, respectively. Recently, this postintervention arterial remodeling process was confirmed by a serial volumetric (three-dimensional) IVUS analysis. 114 Patients with diabetes appear to respond differently to coronary interventions. 115 Although both diabetics and nondiabetics develop adventitial constriction to produce late lumen loss in nonstented lesions, diabetics show exaggerated tissue proliferation, which may explain their increased rate of restenosis.
Future strategies to reduce restenosis should target prevention of late constrictive remodeling and enhancement of adaptive remodeling as well as suppression of intimal hyperplasia.
Directional Atherectomy
Directional Atherectomy (DCA) was introduced to reduce the restenosis rate compared with balloon angioplasty; however, two initial randomized trials reported no significant benefit with this technique. 60 It should be noted that when DCA is performed with IVUS guidance, the procedure is performed in an iterative fashion. 131 That is, after an adequate number of cuts with the DCA device, IVUS imaging is performed. The DCA device is then reinserted and directed to the quadrants that reveal residual plaque by IVUS. In addition, if IVUS reveals that a section of plaque has been removed from the artery wall and only the media and adventitia remain, then the DCA device is directed away from those quadrants. 132 Figure 19 
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shows that IVUS can identify if the media or adventitia has been removed by DCA and this may not be evident by angiography. This method of IVUS-guided DCA therefore improves the safety of the procedure and maximizes the amount of material that is removed. In the CAVEAT Trial, IVUS imaging was not used, and it is likely that a greater amount of plaque was left behind than was appreciated by angiography. 60 Because the stretching effect was probably significant in that study, it may help explain why the restenosis rate was similar to the group treated with angioplasty alone (50% v 57%). With this new awareness, other DCA trials were designed to be more aggressive. In the Optimal Atherectomy Restenosis Study (OARS) Trial, directional atherectomy was optimized and the restenosis rate was reduced significantly to 29%. 133 In the Adjunctive Balloon Angioplasty following Coronary Atherectomy Study (ABACAS) Trial, IVUS imaging was used to guide the atherectomy so that a residual plaque cross-sectional area (CSA) of 47% was left. 134 This resulted in a restenosis rate of 21%.
These observations have led to a renewed interest in debulking lesions under IVUS guidance before stenting.
Stents and IVUS
The Influence of Stent Deployment on Subacute Thrombosis
When stents were initially used, the primary concern was the high rate of subacute stent thrombosis that inhibited the widespread use of coronary stents. [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] Initial observations of coronary stents with IVUS led us to an alternative explanation of why sub-acute stent thrombosis occurred. The first observation by IVUS was that 
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there often was incomplete apposition of the metal struts against the arterial wall. 150 As shown in Fig 20, despite the use of a large balloon and a successful angiographic result, IVUS showed that the stent struts were not fully apposed to the arterial wall and were stranded in the middle of the lumen. By using a larger balloon, the stent struts were appropriately positioned against the arterial plaque. The second observation was that a number of stents were asymmetrically deployed, as shown in Fig 21. At the time this was thought to create turbulent flow and to be another initiating factor for subacute thrombosis. Based on these ultrasound observations, stents were redilated with either a larger balloon or at higher pressures to attempt to get a more symmetrical distribution of lumen shape. 151 The third observation provided by IVUS imaging was that many stents were inadequately expanded despite what appeared to be an appropriate angiographic result, as seen in Fig 22 .
The Predictors and Outcomes of Stent Thrombosis (POST) registry 152 showed that 90% of patients with subacute thrombosis had IVUSdefined abnormalities, whereas only 25% of angiograms showed an abnormality that could explain why thrombosis occurred. These types of observations with IVUS led us to believe that the high incidence of subacute stent thrombosis was perhaps not as much due to any inherent thrombogenicity of the metal and the presence of a foreign body in the artery, as much as it was due to inadequate deployment with an insufficient lumen crosssectional area resulting in diminished flow or turbulence that would promote thrombosis. 130 
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Coronary Artery Stenting with IVUS Guidance but Without Coumadin
When the Palmaz-Schatz and Gianturco-Roubin stents were first released, an attempt was made to diminish the catastrophic sequelae of subacute stent thrombosis by using an aggressive anticoagulation regimen. 61, 143, 153, 154 This included heparinization following the procedure until an adequate elevation of the protime could be obtained with coumadin. This prolonged the hospital stay and produced major bleeding complications at the site of the arterial puncture. 155 Given the results of the ultrasound observations of the large lumen area that could be achieved with IVUS guidance, we withheld coumadin from the stented patients and slowly began to diminish the time of heparin treatment following the procedure. In addition, the antiplatelet regimen of aspirin was augmented with ticlopidine. The results of this study were published in 1995 and had a significant impact on the way that coronary artery stenting has since been performed. 156 By deploying stents with IVUS guidance, subacute thrombosis occurred in only 1.4% despite the absence of coumadin therapy or heparin following the procedure. Without the use of an aggressive anticoagulation regime, the vascular complication rate was significantly reduced to 0.6%. The hospital stay was decreased from an average of 5 days with coumadin therapy to 1 day. Moreover, the final minimum lumen diameter was markedly improved to 3.39 mm as compared with the results that were obtained without ultrasound guidance, such as the Stent Restenosis Study (STRESS) or Belgium Netherland Stent Investigators (BENESTENT) Trial, where the mean final Minimum Lumen Diameter (MLD) in the stent group was 2.45 mm and 2.48 mm, respectively. 61, 62, 157 Using our approach, the overall angiographic restenosis rate at 6 months was 20%, and was 14% for single stents, which was significantly lower than 29% reported in the STRESS Trial.
The technique of larger balloons and higher pressure inflations to deploy coronary artery stents without subsequent anticoagulation was 
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rapidly adopted by most interventional cardiologists. Subsequent papers showed a marked reduction in subacute stent thrombosis, vascular complications, and patient stay. 158-161 Several authors also reported excellent results using this balloon dilatation strategy without IVUS guidance to assess their results. [162] [163] [164] It now appears that IVUS imaging is not necessary to obtain a low incidence of subacute stent thrombosis. [165] [166] [167] There still are other potential advantages of using IVUS during stent deployment, the most significant of which is the influence of ultrasound guidance on restenosis, which is discussed next.
Can IVUS Improve Late Outcomes?
From a retrospective analysis of 2,343 stented lesions comparing IVUS and no-IVUS guidance, 168 the group with IVUS guidance had a larger final minimal luminal diameter and a smaller final percent diameter stenosis as well as a significantly lower restenosis rate (24% v 29%, P ϭ .03). The recent Can Routine Ultrasound Improve Stent Expansion (CRUISE) Trial 169 also showed such an effect. The preliminary results of this trial showed a significant reduction in the need for lesion revascularization in the patients treated with IVUS guidance as compared with angiographic guidance (8.9% v 14.8%, P ϭ .004). The preliminary results of the Angiography Versus IVUS-Directed Stent Placement (AVID) Trial 170 showed a 1-mm 2 increase in minimum stent area with IVUS guidance compared with angiographic guidance alone. These studies indicate that IVUS imaging can improve late outcomes by permitting a larger lumen to be obtained during stent implantation. 
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Fig 22.
The baseline study reveals an ostial stenosis of a saphenous vein graft that is significant both by angiography as well as by ultrasound. Following inflation of the stent with a 4-mm balloon at 6 atm (which at the time was the recommended pressure) the angiographic result is significantly improved; however, the ultrasound cross-sectional lumen area was only 3.4 mm 2 . By using higher pressures (12 atm) with the same balloon we were able to increase the dimensions to 5 mm 2 . By using a larger balloon and higher pressure the final result was 10.2 mm 2 . This use of IVUS-guided stent deployment increased the residual lumen cross sectional area 300% from 3.4 to 10.2 mm 2 . 
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Undeployed Stents
One of the most dramatic examples of a case in which IVUS imaging has been essential for understanding complications that occur with coronary artery stenting is the discovery of a stent that has slipped off the delivery balloon and is sitting in the artery in an undeployed state. An example of this is provided in Figs 23 and 24.
Tissue Prolapse Through Stent Struts
IVUS can identify the presence of tissue prolapse through stent struts. Prolapse of atherosclerotic plaque into the lumen through stent struts may be a precipitating cause of subacute stent thrombosis or restenosis. This problem is rarely identified by angiography alone.
An example of this is shown in Fig 25 .
Complex Anatomy During Stent Implantation
Coronary stenting reduces restenosis and clinical events in focal de novo lesions compared with balloon angioplasty. 61,62,157 However, when stents are implanted in complex lesion subsets, such as ostial lesions, lesions at bifurcations, or in the left main artery, bypass grafts, and small vessels, the process of stenting is technically challenging and restenosis remains a problem. IVUS provides important information in such situations and may facilitate the procedure or reduce the risk of complications.
Ostial Lesions
Aorto-ostial stenosis is a rare manifestation of multivessel coronary artery disease. The incidence varies between 0.13% and 2.7% of patients with angiographic coronary disease. [171] [172] [173] On the other hand, non-aorto-ostial stenosis is not an uncommon finding in patients with atherosclerosis. Although the efficacy of surgical revascularization in patients with ostial stenosis is well recognized, 174 catheter-based coronary revascularization also has been applied successfully to this lesion subset. With improvements in operator experience, angioplasty technique, and evolution of equipment, the successful treatment of ostial lesions has evolved.
Aorto-ostial stenosis. The treatment of aortoostial lesions by conventional balloon angioplasty 175, 176 and other devices, such as laser 177 or directional atherectomy, 178 has been limited by a low success rate and high incidence of restenosis. Coronary stenting is an attractive alternative for this subset of lesions because it provides the necessary scaffolding to support the artery. 179 However, preparing the lesion for a stent with balloon dilatation may be a significant challenge because these lesions tend to have a high incidence of calcification 180 or are very resistant because the balloon has to stretch against the longitudinal direction of the aortic wall. To address these issues, rotational atherectomy or directional atherectomy is frequently performed before stenting to debulk the plaque and prepare the entrance for the stent.
Stent implantation in the aorto-ostial location is technically challenging because of difficulties in seating the guiding catheter, obtaining adequate images to enhance stent placement, ensuring proper stent position to adequately cover the entire lesion, and preventing stent migration or embolization. Precise stent placement can be facilitated by using a stent that is clearly visible, such as the Palmaz biliary or MultiLink Duet stent. Moreover, the use of IVUS guidance is critical for optimum deployment and correct positioning during ostial lesion stenting. The ultrasound images are used to determine the media-to-media diameter of the vessel, which in 
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turn allows us to choose the correct stent and balloon size. In addition, contrast can be injected under fluoroscopy during ultrasound imaging to correlate the exact ostium of the artery with the angiographic appearance in the view that we are going to place the stent. The ultrasound distinction between the aorta and the ostium of the artery is very obvious and is not obscured by the superimposed projection of the sinus of valsalva and the ostium of the artery as occurs with x-ray imaging. After the stent is placed and expanded to high pressure, the artery and stent are again interrogated with IVUS to confirm that the stent struts extend right up to the ostium or perhaps 1 mm beyond into the aorta. If the ostium appears compromised or the stent is not within 1 mm of the true ostium, then a second stent should be placed.
Another concern when stenting ostial lesions is the higher restenosis rate. The best approach for decreasing restenosis in ostial lesions should be to maximize the lumen cross-sectional area. This can be obtained by: (1) debulking the lesion with rotational atherectomy or directional atherectomy, (2) using a stent that has very high radial strength such as the Palmaz biliary stent, and (3) expanding the stent with an optimally sized balloon as determined by IVUS measurements of the media-to-media diameter.
An example of treating an aorto-ostial lesion is presented in Figs 26 and 27.
Non-aorto-ostial stenosis. Although stenoses of the initial portion of the LAD or circumflex arteries are referred to as ostial lesions, these differ somewhat from the true aorto-ostial lesions described above. The obvious difference is that the takeoff of these vessels is not from the aorta itself so that the ostial LAD or circumflex lesion usually does not have the same resistance as a true aorto-ostial lesion. The other major difference between these two sets of lesions is that the LAD or circumflex ostial lesion frequently involves the bifurcation either because the disease extends into the bifurcation, although it may not be apparent by angiography, or placement of the 
Bifurcations
The treatment of stenoses at a bifurcation remains one of the most challenging lesion subsets in coronary angioplasty. Bifurcation lesions carry a risk of side branch occlusion because of plaque redistribution or so-called ''plaque shift'' across the carina of the bifurcation. The risk is increased if there is an eccentric lesion at the bifurcation site and a stenosis in the ostium of the side branch. 181, 182 To diminish this plaque shifting, the ''kissing'' balloon technique was developed. 183 
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However, the results with balloon dilatation of bifurcation lesions still had a high incidence of complications, suboptimal results, and restenosis. 181, [184] [185] [186] Treatment of bifurcations with directional atherectomy (without stenting) has been shown to improve the immediate procedural outcome compared with balloon dilatation alone, but the incidence of restenosis remains high. 187 The use of coronary stents has improved the treatment of bifurcation lesions, but it is technically challenging and there is still a high incidence of compromising the branch vessel. [188] [189] [190] Stent implantation on both the main vessel and the side branch, which is called ''kissing stents,'' is a useful technique for maintaining maximum expansion of both vessels. The use of two stents minimizes lumen loss of one side during expansion of the other branch. 191 The four main techniques used for bifurcation stenting (the coil stent, the ''T'' stent, the ''Y'' stent, and the ''V'' stent technique) have been described step by step with their advantages and disadvantages. 192 Whatever technique is selected, IVUS guidance is of critical importance for optimizing the result. Bifurcation lesions are very difficult to examine completely despite multiple angiographic projections because of vessel overlap. IVUS imaging can facilitate placement of the stents and confirm An acceptable angiographic result was obtained. IVUS was then performed to confirm that the stent had been placed precisely at the ostium without obstructing the circumflex artery. The ultrasound images provided a surprise. The reflections from the metallic stent struts were seen in the mid (A) and distal left main artery (D) and no stent struts were seen at the ostium of the LAD (C). In addition, the stent struts were only mildly expanded in the distal left main and were not expanded at all in the mid left main. This indicates that the stent had slipped off of the balloon and migrated to the more proximal left main artery.
LIMITATIONS OF CORONARY ANGIOGRAPHY
optimal lesion coverage, stent expansion, and strut apposition. 192 In addition, if feasible, bifurcation lesions should be pretreated with rotational atherectomy, or directional atherectomy, to diminish plaque shifting. The choice of device is aided by the use of preintervention IVUS imaging according to the composition and distribution of plaque and the size of the vessel. Compression of the adjacent branch is enhanced after stenting because of the absence of mural support at the carina. In addition, the larger balloon size and high pressure applied to achieve large luminal gain and optimal stent expansion may compromise the ostium of side branches in bifurcation lesions. 192 On occasion, a three-dimensional reconstruction of the IVUS images obtained on pullback may be helpful for understanding the anatomy immediately surrounding a bifurcation. An example of this is provided in Fig 31. 
Left Main Artery Stenting
In contrast to ''protected'' left main (LM) stenosis, that is, at least one patent coronary artery bypass graft supplying the left coronary artery system, ''unprotected'' LM stenosis has been considered a contraindication for percutaneous catheter-based revascularization. During balloon angioplasty there may be severe hemodynamic compromise, or disastrous consequences following abrupt vessel closure. Recent advances in stent implantation techniques 156 and poststent antithrombotic regimens 193, 194 have caused some centers to reconsider the role of percutaneous treatment of patients with unprotected LM stenoses. Several groups have reported acceptable short-and longterm results in treating LM stenosis. [195] [196] [197] [198] [199] [200] [201] [202] IVUS is an important adjunctive imaging modality for LM intervention. Despite its clinical significance, LM disease may not be accurately evaluated by coronary angiography alone. 203, 204 In addition, stenting the LM lesion has several unique characteristics. By IVUS, the LM is frequently 5 mm in diameter (media to media) despite the narrowed appearance by angiography. Compared with the rest of the artery, there is a much larger amount of plaque per cross-sectional area. Because the risk of restenosis is critical when stenting the LM, debulking the lesion before stenting is preferred, which not only facilitates deployment of the stent but should lower the restenosis rate by half. IVUS provides accurate sizing of the LM and visualizes the amount of plaque that may need to be removed. Operators must pay attention to the differences between placing a stent at the aortoostial junction, in the body of the LM, or if the lesion encompasses the bifurcation of the LAD and circumflex arteries. Even though an angiogram shows a stenosis isolated to the body of the LM, there may be involvement of the bifurcation that is not appreciated until IVUS is performed. The information that IVUS provides is important in planning the approach to this high-risk lesion subset. Figure 32 is an example in which IVUS enabled optimal stent implantation for a LM trunk stenosis. 
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Bypass Grafts
The treatment of patients with obstructive disease in coronary artery bypass grafts poses a challenge of increasing magnitude as the population of patients who have undergone bypass surgery continues to grow.
Saphenous vein graft. Within a decade after surgery, half of all saphenous vein bypass grafts have severe atherosclerotic disease. [205] [206] [207] [208] [209] Management of graft disease is problematic, because repeat surgery entails substantial risk, and the results of conventional angioplasty have been disappointing. 176, [210] [211] [212] [213] [214] [215] [216] However, recent studies have suggested more favorable results in diseased vein grafts. [217] [218] [219] [220] [221] As compared with repeat coronary artery bypass grafts, it was reported that catheter-based revascularization procedures have similar efficacy for the patient with vein graft disease in the new device era and that the choice of therapy should consider patient preference as well as clinical and angiographic suitability. 222 Although some authors indicate that revascularization strategies in saphenous vein grafts are less often influenced by IVUS than in native arteries, 223 other authors have shown that IVUS provides useful information when applied to this lesion subset. 224 Vein grafts may have variations in their external width that lead to an underestimation, compared with angiography, of the diffuseness of the disease. 225 IVUS enables accurate device sizing by measuring the true diameter of the graft at the lesion site. This is particularly useful for appropriate sizing of stents in these large conduits. One report showed that with angiographic guidance, only 9% of stents were optimally expanded to match the reference crosssectional area. 226 Of the various stents currently available, the Wallstent has been found to be a useful device for treating saphenous vein graft stenosis. 230 Because the disease process in vein grafts tends to be diffuse and the conduits are long, the selfexpanding Wallstent is ideal for this application. In addition, the Wallstent comes in variable lengths and diameters. Covered stents such as an autologous saphenous vein-covered stent 231 or polytetrafluoroethylene (PTFE)-covered stent 232 may have additional advantages in treating degenerated lesions. Covered stents may prevent prolapse of friable tissue through the stent struts and thereby decrease embolization. Preintervention IVUS examination can assist in making these critical decisions.
Small Vessels
One of the important anatomic factors of restenosis after balloon angioplasty, DCA, or stenting is vessel size because the restenosis rate is inversely related to the reference vessel diameter. 62, 233, 234 The advantage of stenting instead of using balloon angioplasty in small vessels is still controversial. A retrospective study suggested that balloon angioplasty was equivalent to stents in patients with small vessels. 235 On the other hand, two studies indicated that stenting was more efficacious than balloon angioplasty for small vessels between 2.6 and 3.0 mm in diameter. 236, 237 Although the immediate success rate and complications in stenting small vessels may be equivalent to those found in larger vessels, the 6-month restenosis rate is higher in smaller vessels (19.9% v 32.6%). 238, 239 The fact that intimal hyperplasia at follow-up was independent of stent size might explain the high restenosis rate in small vessels after stenting. [240] [241] [242] IVUS may potentially improve the outcome of stenting small vessels. Akiyama 238 analyzed patients who received coronary stents in a small (less than 3.0 mm) artery with or without IVUS guidance. The restenosis rate was significantly lower when IVUS guidance was used (29% with IVUS guidance v 38% without, P ϭ .04). The use of IVUS guidance was thought to facilitate decision making in terms of balloon sizing, especially in angiographically small vessels that might in fact be large vessels with diffuse atherosclerosis. It was hypothesized that a greater balloon-to-vessel ratio used in the small-vessel group might have led to greater wall injury and more reactive neointimal proliferation followed by a higher restenosis rate. 243 However, this was recently denied by several studies. 238, 242 The discrepancy between angiography and IVUS of accurately determining reference diameter is shown in Fig 33. 
Debulking Before Stenting
Restenosis remains a problem when stents are implanted in complex lesion subsets, such as long lesions, 244,245 ostial lesions, 179, 246, 247 chronic total occlusions, [248] [249] [250] [251] [252] and bifurcation lesions. 253 Restenosis after implantation of slotted tube stents is The proximal reference was measured as 2.3 mm and the distal reference was 2.7 mm, giving an average reference of 2.5 mm. However, by IVUS, the media-to-media diameter was 3.5 mm, both proximally and distally. Based on this observation, the decision was made to debulk the lesion with rotational atherectomy. A larger burr (2.0 mm) and a larger balloon (3.25 mm) were used than would have been chosen if the decision were based on angiographic guidance. In addition, a stent was placed with greater expansion than would be deemed appropriate based on the angiographic measurement alone.
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mainly due to neointimal proliferation. 254 Observational IVUS data indicate that a larger plaque burden, either before 241,255 or after stenting, 256 leads to a higher rate of late lumen loss after stenting. In addition, angiographic data 257 indicate that after stent implantation, restenosis tends to occur at the original lesion site (where the plaque burden is largest). Based on these observations, it was proposed that removal of atherosclerotic plaque before stenting would lead to a reduction in neointimal hyperplasia, thereby reducing the incidence of restenosis. Recently, several studies have supported this hypothesis. Two different debulking devices were applied before stenting according to the lesion characteristics: directional atherectomy for noncalcified large vessels 258-261 and rotational atherectomy for calcified and/or small vessels. [262] [263] [264] 
DCA Plus Stenting
Currently, DCA is the most effective device to remove noncalcified plaque, 133 thus transforming the atherosclerotic arterial wall to a thinner structure that is more compliant to dilatation. 265 Even with optimal atherectomy, compared with PTCA, restenosis remains about 30% with no difference in the need for repeat revascularization at 1-year Fig 35. Using IVUS imaging before the intervention, tissue characterization reveals significant calcification at the lumen plaque interface (A). Therefore, progressive rotational atherectomy burrs were used from 1.5 mm to 2.5 mm (B). Although the lumen was now slightly larger than 2 mm in diameter, the vessel size measured at the media was greater than 4 mm. Based on this IVUS observation, directional atherectomy was performed with a 7 French cutter, which removed a significant amount of plaque (C). At this cross section, the lumen measured 7.3 mm 2 and the area bounded by the media measured 15 mm 2 , giving a lumen-to-vessel ratio of 49%. After removing the bulk of this plaque, a Crown stent was deployed on a 4-mm balloon at 16 atm. The final dimensions of the lumen were 3.0 ؋ 3.5 mm or 8.1 mm 2 (D).
mm inflated at 10 atm in both branches). The final result is shown (B). There was no significant restenosis at the 5-month follow-up angiogram as shown (C).
follow-up. 266 Late lumen loss after DCA has been shown by IVUS to be the result primarily of late arterial constriction in addition to neointimal hyperplasia. 112, 113 Therefore, the failure of stand-alone stenting or stand-alone DCA to reduce restenosis in complex lesion subsets suggested the need to explore the synergistic role of combining both techniques to reduce restenosis. The hypothesis is that plaque removal with DCA before stenting may lower the intensity of late neointimal hyperplasia, reducing the incidence of in-stent restenosis. This hypothesis has been supported by several recent studies that report a better early and late outcome for the DCA-plus-stenting group than the stenting-alone group. [258] [259] [260] [261] This DCA-plus-stenting approach may be optimized by using IVUS to guide the atherectomy cuts, similar to the procedure outlined in the OARS Trial. 133 The data of the Stenting after Optimal Lesion Debulking (SOLD) Registry 258 showed that the lower the residual plaque after DCA, the lower the loss index will be, with an amazing restenosis rate below 5% in the group that achieves an optimal removal of plaque burden using ultrasound guidance. Figure 34 shows the use of directional atherectomy at a bifurcation to optimize the placement of two stents using IVUS guidance.
Rotational Atherectomy Plus Stenting
Rotational atherectomy is the preferred strategy to ablate calcified plaque. 267 Despite the high procedural success rate, significant restenosis rates of 37% to 57% were observed after standalone rotational atherectomy. 268,269 A recent histopathologic study showed that the presence of calcium is a powerful predictor of the amount of plaque burden in atherosclerotic arteries. 270 In addition, in vivo IVUS ultrasound studies have shown that coronary calcium is an important determinant of decreased wall compliance, 271 and it leads to a high incidence of dissections when these lesions are dilated 27 and a high rate of suboptimal expansion when stents are used. 272 It was hypothesized that pretreating the lesion with atheroablative techniques to reduce the calcified plaque burden would improve vessel wall compliance. This in turn would optimize stent expansion and consequently lower the restenosis rate. This hypothesis was supported by recent studies. [262] [263] [264] These authors showed that adjunctive rotational atherectomy before stenting (rotastenting) for calcified or undilatable lesions improved not only the procedural result but also the late outcome. It was also shown that lesion morphology evaluated by IVUS before stent placement identified lesions with a greater likelihood of . Preintervention IVUS was attempted; however, the IVUS catheter could not cross the lesion. Rotational atherectomy was then performed using a stepped burr approach (2.0, 2.25, and 2.38 mm). IVUS imaging postrotablation showed a large residual plaque burden. Therefore, DCA was then performed using a 7 French GTO cutter. Two MultiLink stents were implanted and expanded using a 3.5-mm balloon inflated at 11 atm (B).
Follow-up angiography was performed at 5 months. There was no evidence for restenosis (C).
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eccentric stent expansion and a smaller poststent MLD. 264 Therefore, preintervention IVUS can identify which lesions should be rotablated before stenting.
It remains unclear how aggressively rotational atherectomy should be performed before stenting. Using rotational atherectomy alone, a higher target lesion revascularization rate was reported (25%) when a burr/vessel ratio greater than 0.85 was used. 273 This effect was presumably due to the increased vessel trauma produced by the oversized burr. The use of a coronary stent might eliminate the chronic shrinkage triggered by rotablation with an oversized burr. Aggressive rotablation before stent placement would reduce the plaque burden and improve vessel compliance, and thus possibly reduce the late lumen loss associated with calcified lesions, similar to those reported for noncalcified lesions treated with DCA plus stenting. 258 IVUS provides more precise information than angiography about the amount and position of calcification, residual plaque burden, and vessel size of the target lesion. The use of IVUS in a repetitive process to image the artery before the intervention, after sequential atherectomies, and following stent insertion facilitates the procedure and improves the final lumen crosssectional area within the stent zone.
A case example of the iterative use of IVUS to guide the atherectomy process is shown in Fig 35. An example where IVUS guidance of rotational atherectomy plus directional atherectomy was used to optimize stent placement in the LAD is shown in Fig 36. 
PTCA Provisional Stenting
Although intracoronary stenting represents the only currently available strategy shown to limit both clinical and angiographic restenosis, 61,62,274 it continues to be accompanied by several limitations. Stents are costly 155, 275 and difficult to use with some complex lesion subsets such as bifurcation lesions, [188] [189] [190] 192 lesions in small vessel, 235,238,239 and diffuse long lesions. 168, 276 Most importantly, stents have engendered a new and difficult-to-treat entity of in-stent restenosis. In addition, there are many times when balloon dilatation alone provides an adequate long-term result. To address these issues, the strategy of ''provisional stenting'' has been developed. 277 In this method, an attempt is made to use balloon dilatation alone. IVUS guidance is used to choose the balloon size to obtain the best possible angioplasty result in terms of lumen crosssectional area. However, if ultrasound imaging 
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reveals an inadequate lumen or the presence of a dissection that compromises the lumen, then a stent is placed electively.
Several studies have shown that IVUS can provide essential information during the provisional stenting procedure. In the CLOUT Pilot Trial, 74 Stone reported that the early angiographic and clinical results of IVUS-guided PTCA without stenting were promising. On the basis of the vessel size and extent of plaque burden in the reference segment evaluated by IVUS, 73% of the lesions required larger balloons even after achieving an optimal angiographic result (final balloon/ artery ratio ϭ 1.30 Ϯ 0.17). The success rate of IVUS-guided PTCA was 99%. Only one patient who developed acute closure received a stent. This angiographic oversized balloon angioplasty with IVUS guidance resulted in a larger final MLD without increased rates of significant dissections or ischemic complications. In the Strategy of Intracoronary Ultrasound Guided PTCA and Stenting (SIPS) trial, 278 269 patients (358 lesions) were randomized to IVUS-guided intervention or angiography-guided intervention. Stenting was performed in about 50% of lesions in both groups. Major adverse cardiac events (MACE) during hospitalization were less with the IVUS-guided group. The reduction of MACE by IVUS guidance was 79%. They concluded that IVUS-guided intervention could reduce acute MACE. The Washington Hospital Center reported acute and late benefits of IVUS-guided balloon angioplasty using balloons sized according to the media-tomedia diameter as determined by IVUS. 279 The end point used in this study was achieving a minimum lumen cross sectional area (MLCSA) greater than 70% of the average reference vessel area with no lumen compromising dissections. Crossover to stenting was needed in 61% of lesions. They showed that IVUS-guided PTCA achieved a ''stent-like'' lumen in 39% of patients with no abrupt closure episodes. An acceptable target lesion revascularization rate of 17% was reported. Recently, from a similar analysis for LAD lesions, they reported that 43% of lesions did not need stent implantation, and the target lesion revascularization was only 8.0% at 9 months. 280 Clinical examples of ''provisional stenting'' are shown in Figs 37 and 38. Figure 37 shows how IVUS guidance revealed that placement of a stent was not necessary. Figure 38 shows how IVUS helped determine which of several lesions needed a stent despite the angiographic result.
Recently, a strategy of provisional stenting with a delayed angiogram at 30 minutes was suggested as an alternative to IVUS guidance. 281 It remains to be clarified if this strategy provides comparative results to those with IVUS guidance.
These preliminary results support the utility of IVUS-guided provisional stenting and have provided the impetus to extend this approach to the treatment of long lesions. This technique is called spot stenting and is described in the following paragraph.
IVUS-Guided Spot Stenting
To address the high restenosis rate associated with stenting long lesions or lesions in small vessels, the concept of spot stenting has evolved. The treatment of long lesions and lesions in small vessels has historically yielded poor immediate and long-term results when approached with traditional balloon angioplasty. 236,282-285 Angiographic restenosis rates for these lesions have ranged from 41% to 55%. In the STRESS subanalysis, smaller vessels treated with PTCA had a restenosis rate of 53%. Treatment of focal lesions with coronary stenting in vessels greater than 3.0 mm reduces restenosis when compared with balloon angioplasty. 61,62,274 However, stenosis length, length of the stent deployed, and small reference diameter were reported to be independent predictors of restenosis within stents. 168, 276 Spot stenting is an attempt to use IVUS guidance to treat long lesions by taking advantage of the benefits of balloon angioplasty and reserving the use of stents to treat residual focal stenoses.
Based on the provisional stenting data, it was hypothesized that the restenosis rate for long lesions and diffuse disease could be reduced if IVUS-guided PTCA would be used as the primary modality while reserving coronary stents to those segments of a lesion where lumen dimensions did not meet prespecified IVUS criteria. Instead of traditional stenting where a lesion is covered from a proximal normal segment to a distal normal segment, the concept behind the spot stenting approach is to avoid stenting long segments even if small dissections are left behind, provided that the dilated sections have an adequate lumen CSA by IVUS. Preliminary data to support the use of this approach have been provided. 286 In that report, long lesions (greater than 15 mm) or lesions located in small vessels (less than 3.0 mm) were approached with primary PTCA using a balloon-to-vessel ratio of 1:1. The vessel size was defined as the reference media-to-media diameter measured by a preintervention IVUS study. IVUS criteria for success were defined as achievement of a lumen CSA greater than 50% of the vessel CSA at the lesion site or a minimum lumen CSA greater than 5.5 mm 2 . If the IVUS criteria were met in all segments of the lesion after initial balloon dilatation, the procedure was considered complete. If the IVUS criteria were not met, the operator would consider using a larger balloon or higher pressure if deemed possible. If this were not possible, a stent was implanted focally only in 
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the segment or segments of the lesion where the IVUS criteria had not been achieved, taking care to use the shortest stent length necessary to obtain an optimal result. Fifty percent of all treated lesions achieved the IVUS criteria with PTCA alone, whereas the other 50% required the placement of a focal stent. The average stent length used in the lesions that did not meet IVUS criteria by PTCA alone was 19.0 Ϯ 12 mm. This was actually shorter than the average lesion length (20.7 Ϯ 12 mm). In contrast, in previous studies it was common that stent length significantly exceeded lesion length, such as in the STRESS, BENESTENT I, and BENESTENT II Trials. 61, 62, 165 This is an important concept because evidence shows that the length of deployed stent is a major contributing factor to restenosis. 168, 276 Overall results for this approach in 109 lesions in 71 patients were reported as follows: a MACE occurred in 25%, the angiographic restenosis rate was 18%, and the target lesion revascularization rate was 15%. This approach of IVUSguided PTCA with spot stenting allowed safe treatment of long lesions and lesions in small vessels and achieved 6-month MACE and restenosis rates that appear to be lower compared with historic controls in these difficult lesion subsets. In addition to maximizing the acute gain, IVUS plays an essential role for this approach in terms of procedural safety. Historically, balloon angioplasty performed with angiographically oversized balloons without IVUS guidance was reported to be associated with a poor outcome. 66,67 Furthermore, placing a stent without fully covering the lesion has been viewed as dangerous because of the theoretical risk of acute or subacute stent thrombosis due to the potential flow disturbance and lesion reactivity. However, when IVUS is used to guide the intervention, any flow limiting segments or dissections can be more accurately assessed and a more educated decision made as to whether this segment can be left untreated. 287 The incidence of acute and subacute thrombosis in the spot stenting trial was as low as any of the major stent trials where less complex lesions were treated. This lesion was 56 mm in length, and the reference lumen diameter measured 2.55 mm by QCA. QCA measurements in sizing vessels has been shown to be less accurate than IVUS measurements, especially in small vessels and vessels with diffuse disease. A long tapering balloon was used for predilatation that was 60 mm in length and tapered from 3.2 mm in diameter in the proximal portion to 2.0 mm in the distal portion. After the first inflation to 8 atm, IVUS was performed and showed that the lesion in the mid to distal segment of the artery was fibrocalcific in nature and that the media-tomedia diameter in the distal lesion was 3.2 mm (B). Based on these observations, a 3.0-mm cutting balloon was applied only in the mid to distal segment of the lesion where the lumen CSA did not meet our minimal criteria.
An example of the spot stenting strategy is shown in Fig 39. An example of spot stenting with a 6-month follow-up study is shown in Fig 40. 
Treatment of In-Stent Restenosis
With the explosion in the use of intracoronary stents in recent years, the problem of in-stent restenosis has been receiving increased attention. Ideally, to minimize further recurrences, the management of in-stent restenosis should not only address the new tissue growth but also the predilection for the exuberant proliferative response present in such lesions. Balloon angioplasty is safe, relatively inexpensive, and appears to be reasonably effective for focal in-stent restenosis. 288, 289 Debulking devices such as DCA, 95 rotational atherectomy, 290,291 laser atherectomy, 292, 293 and other tools such as the cutting balloon, 294,295 also appear to be safe and possibly somewhat more effective than balloon angioplasty. However, they have limited power to reduce rerestenosis so that optimal strategies need to be defined. Additional stents might be effective, [296] [297] [298] [299] [300] [301] especially in combination with the use of antiproliferative strategies such as radiation therapy. 302 Additional stents should be used to cover important dissections occurring in the therapy of in-stent restenosis 303 and also may be effective in reducing the problem of ''instant'' restenosis, 304 ie, recoil of fibrous tissue through the stent struts back into the lumen.
How does IVUS help during treatment of this lesion subset? IVUS may be helpful by detecting ''pseudo-in-stent restenosis'' 305 and ''instant'' restenosis 304 better than angiography.
Pseudo-In-Stent Restenosis
After the implantation of a rigid slotted tube stent, neointimal proliferation occurs in response to the barotrauma applied to the vessel wall as Fig 39. (Cont'd) The cutting balloon was effective in achieving the minimal criteria in the more distal segment where the lumen by IVUS now measured greater than 50% of the reference vessel area (C). In the mid portion, the luminal result was still unsatisfactory, with a CSA of 2.8 mm 2 , so a stent was deployed only in the mid segment. This stent was 30 mm in length and was postdilated with a 3.5-mm balloon to 16 atm. The final angiogram shows an excellent result, and the IVUS measurement shows the new CSA in the mid portion to be 6.7 mm 2 (D). Fig 40. The initial approach to this subtotal occlusion in the right coronary artery was to use balloon angioplasty followed by a cutting balloon (A). This produced a good angiographic result. IVUS interrogation showed that there was an inadequate CSA in the mid portion (CSA less than 5.5 mm 2 and less than 50% of the reference vessel area at the lesion site) even though there was an optimal angiographic result (B). The lumen in the distal portion met minimal criteria of being greater than 50% of the vessel area. The final step was to place a 15-mm BX stent only in the specific site with the inadequate result in the mid portion. The 6-month angiographic follow-up showed an excellent long-term result with minimal recoil and little intimal hyperplasia (C).
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well as the persistent irritation of the foreign body. 254, 306 Pseudo-in-stent restenosis is defined as a stenotic lesion within the stent at follow-up that is caused by inadequate stent expansion during the initial use rather than intimal hyperplasia (Fig 41) . Alternatively, a stent may be compressed by external vessel recoil 305 (Fig 42) . If the stent is not radio-opaque, the cause of the angio- 
graphic restenosis may not be appreciated unless IVUS is performed.
The ''Instant'' In-Stent Restenosis
The concept of ''instant'' in-stent restenosis, termed by the Washington Hospital Center group, was derived from the observation that, although the neo-intimal tissue decreased immediately after balloon angioplasty (or ablative therapy) for instent restenosis, it might recur after only a few minutes by prolapse of the extruded tissue. 304 Placement of an additional stent prevents this tissue from reentering the lumen. 299 IVUS should 
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detect this phenomenon with greater sensitivity than angiography and help determine whether additional stenting is necessary. Despite these favorable results on acute luminal results, the subsequent event rate has been high after repeat stent implantation to treat in-stent restenosis (Fig 43) .
Limitations of IVUS
Despite the many benefits to using IVUS as an adjunct to coronary angiography, there clearly are several limitations of this method. First, with a simple injection of contrast, angiography can delineate a coronary artery with its branches, whereas IVUS imaging can examine only one artery at a time. Additional passes are needed to assess branch vessels. Second, IVUS can examine only the portion of the artery that accommodates the diameter of the IVUS catheter, which is more than 2.5 F at the present time. Third, IVUS images may be blemished by artifacts that interfere with the correct interpretation of the image. This includes ringdown artifact, guide wire artifact, acoustic shadowing, position-related artifacts, movement artifacts, and nonuniform rotational distortion. 307 Fourth, some IVUS systems have an acoustic dead zone around the catheter on the image, which may limit the evaluation of lesions with very tight stenosis. 308 Fifth, IVUS cannot evaluate angulation of the arterial segment because the device provides an instantaneous crosssectional view along the length of the artery. Three-dimensional reconstructions stack up these slices into a straight line. In addition, the IVUS catheter may mechanically straighten a bend in the artery. This occasionally produces a false negative ultrasound result. An interesting case example of this is shown in Fig 44. 
Summary
This review has attempted to show the areas where IVUS may provide additional information that is not available by angiography alone. Not only does the use of IVUS facilitate the performance of interventional procedures, especially in complex lesion subsets, the use of IVUS may lead to lower complication rates as well as improved restenosis data and target lesion revascularization. These advantages of IVUS have led to a cost-benefit analysis that suggests that the use of IVUS guidance is cost-effective. 169 
